[updated: 09/10/2021] Expedia Stock Update
Expedia’s stock (NASDAQ: EXPE) has gained 48%, moving from about $100 to $147 in the last twelve months. However, the company’s revenues have fallen 36% to a consolidated figure of $5.8 Bil for the last four quarters from the consolidated figure of $9 Bil for the four-quarter period previously. This revenue and stock price mismatch looks like a reason to be wary of the stock – as EXPE stock remains highly valued at a price-to-sales ratio of 3.8x (given that Expedia’s P/S was around 1.5x during the 2018-2019 period). This is based on the travel company’s disappointing Q2 results and warning of a bumpy recovery following the pandemic. Our dashboard, Buy or Fear Expedia Stock? provides the key numbers behind our thinking, and we explain more below.
In Q2, Expedia’s revenue of $2.11 billion was up sequentially from Q1 2021 revenue of $1.25 billion. However, it was still 24% below the $2.78 billion mark that it reached in the pre-Covid quarter. As a percentage of total worldwide revenue for Q2 2021, lodging made up 73%, advertising and media accounted for 8%, and air accounted for just 4%, and the rest came from other services. Expedia Group benefited from strong vacation rental performance and improved conventional lodging, offset by continued softness in international travel, corporate travel, and relatively high consumer interest in smaller markets and lower-end accommodations. Going into Q3, recent Covid variants around the world could likely continue to create uncertainty in the travel industry. While the U.S. has been following an aggressive drive to vaccinate its population with 53% already fully vaccinated, the number is quite low at 28% on the global level. Mass vaccinations are definitely helping the travel industry to recover, but the full recovery remains in doubt until most of the world is completely vaccinated.
Expedia’s stock grew 18% from around $113 at the end of fiscal 2018 to around $132 at the end of fiscal 2020. While the company’s revenue per share declined a sizeable 50% during this period – thanks to the pandemic restrictions, the company’s stock price climbed at the end of fiscal 2020 on the optimism of vaccine trial news. It should also be noted that Expedia’s P/S was around 1.5x during the 2018-2019 period. It appeared higher in 2020 as the reported drop in RPS led the P/S ratio to appear higher at that point. The company’s P/S ratio grew from about 1.5x at the end of FY 2018 to 3.7x at the end of FY 2020. While the company’s P/S is about 3.8x now, we expect this figure to decline modestly closer to historical levels.
[updated: 08/04/2021] Expedia Q2 Pre-Earnings
Expedia (NASDAQ: EXPE), a travel company providing everything from airline tickets, hotel rooms, car rentals, to cruises, is scheduled to announce its fiscal second-quarter results on Thursday, August 5. We expect Expedia’s stock to likely trade higher due to revenues and earnings beating consensus estimates. Expedia saw a slower decline (as compared to a steep fall last year) in retail, reflecting improvements in leisure travel trends in Q1, particularly in North America. In addition, it saw a 10% increase in revenue per room night in Q1, as it benefited from an increase in the percentage of alternative accommodation (Vrbo) stayed room nights, which have a higher revenue per room night. Although Expedia does not break out Vrbo numbers, the company’s management reported that it benefited from its vacation rental business and domestic business in the U.S. in Q1. Having said that, Covid-19-related restrictions relatively eased in the U.S. during Q2, which accounts for 67% of total Expedia revenues – signaling an improving trend going forward. While Expedia still has a long way to grow its operating metrics similar to 2019 levels, mass vaccinations are definitely helping the travel industry to recover. To add to this, Expedia also announced its intention to sell its corporate business arm, Egencia, to focus better on its core technology and B2B business. This sell-off is a part of Expedia’s move to further streamline operations.
Our forecast indicates that Expedia’s valuation is $184 per share, which is 19% higher than the current market price of around $155. Look at our interactive dashboard analysis on Expedia Pre-Earnings: What To Expect in Q2? for more details.
(1) Revenues expected to be ahead of the consensus estimates
Trefis estimates Expedia’s Q2 2021 revenues to be around $2.1 Bil, 5% higher than the consensus estimate. Expedia Group total revenue in Q1 2021 decreased 44% year-over-year (y-o-y) to $1.2 billion but grew nearly 36% sequentially from $920 million in Q4 2020. Particularly in Q1, the group’s retail segment revenue declined 35%, and its B2B segment’s revenue decreased 62%. As a percentage of total worldwide revenue for Q1 2021, lodging made up 72%, advertising and media accounted for 7%, and air accounted for just 4%, and the rest came from other services. Adjusted EBITDA for the first quarter of 2021 was a loss of $58 million, a decrease of 24% compared to Q1 2020.
For the full year 2021, we expect Expedia revenues to grow 58% y-o-y to $8.2 billion.
(2) EPS likely to beat consensus estimates
Expedia’s Q2 2021 earnings per share (EPS) is expected to come in at a loss of $-0.50 as per Trefis analysis, marginally better than the consensus estimate of -$0.65. The travel company reported earnings at a loss of $4.17 in Q1 as compared to a loss of $9.24 in the same period last year. In the long term, Expedia needs to address its $4.6 billion negative free cash flow in 2020 that compares to $1.6 billion in positive free cash flow the previous year. So, it needs to generate at least $6 billion to return to normalcy, of which it totaled $2 billion in Q1. While Expedia still has $4.3 billion in unrestricted cash and short-term investments and $2 billion in an untapped revolver capacity, reducing its large debt of $8.5 billion will rely heavily on the company’s post-pandemic recovery.
(3) Stock price estimate higher than the current market price
Going by our Expedia’s Valuation, with a revenue per share (RPS) estimate of around $58.40 and P/S multiple of around 3.2x in fiscal 2020, this translates into a price of $184, which is 19% higher than the current market price of around 155.
It is helpful to see how peers stack up. EXPE Stock Comparison With Peers for how Expedia compares against peers on metrics that matter.